DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)

DongKoo Bio & Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	146,839	131,049	156,349	169,609	232,556	240,580
Market Cap Growth	4.43%	-16.18%	-7.82%	-27.07%	-3.33%	-
Enterprise Value	231,344	172,921	172,036	175,056	221,869	244,593
Last Close Price	5430.00	4694.12	5398.48	5731.92	7541.16	7564.67
PE Ratio	190.77	64.38	13.24	25.64	24.94	26.32
PS Ratio	0.62	0.53	0.73	0.87	1.50	1.73
PB Ratio	1.33	1.24	1.42	1.66	2.32	2.54
P/TBV Ratio	1.40	1.42	1.57	1.82	2.40	2.60
P/FCF Ratio	-	-	-	14.32	17.05	108.33
P/OCF Ratio	-	7.56	43.61	10.08	12.99	32.13
EV/Sales Ratio	0.97	0.69	0.80	0.90	1.43	1.76
EV/EBITDA Ratio	15.59	8.66	8.33	7.79	16.82	20.19
EV/EBIT Ratio	38.75	13.63	11.77	10.40	27.26	32.14
EV/FCF Ratio	-12.45	-	-	14.78	16.27	110.14
Debt / Equity Ratio	0.97	0.82	0.40	0.34	0.24	0.25
Debt / EBITDA Ratio	7.21	4.34	2.12	1.53	1.84	1.96
Debt / FCF Ratio	-	-	-	2.90	1.78	10.69
Net Debt / Equity Ratio	0.76	0.48	0.19	-0.01	-0.08	-0.06
Net Debt / EBITDA Ratio	5.69	2.52	1.01	-0.04	-0.59	-0.48
Net Debt / FCF Ratio	-4.55	-11.14	-2.04	-0.07	-0.57	-2.63
Asset Turnover	0.94	1.15	1.19	1.19	1.04	-
Inventory Turnover	1.98	2.20	2.26	2.74	2.52	-
Quick Ratio	0.41	0.50	0.61	0.83	0.97	1.17
Current Ratio	0.93	0.93	1.21	1.32	1.48	1.79
Return on Equity (ROE)	0.63%	1.84%	11.11%	6.54%	9.58%	-
Return on Assets (ROA)	1.47%	3.65%	5.03%	6.44%	3.40%	-
Return on Invested Capital (ROIC)	3.08%	4.61%	10.07%	14.53%	7.40%	10.35%
Return on Capital Employed (ROCE)	4.00%	9.90%	12.40%	15.90%	7.80%	7.30%
Earnings Yield	0.52%	1.55%	7.56%	3.90%	4.01%	3.80%
FCF Yield	-12.65%	-3.45%	-6.56%	6.98%	5.86%	0.92%
Payout Ratio	421.26%	162.74%	25.72%	42.39%	10.11%	10.32%
Buyback Yield / Dilution	-1.26%	1.13%	0.48%	1.78%	0.12%	-25.96%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.